These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

166 related items for PubMed ID: 18997102

  • 1. Hyperlipidemic chicken as a model of non-alcoholic steatohepatitis.
    Ayala I, Castillo AM, Adánez G, Fernández-Rufete A, Pérez BG, Castells MT.
    Exp Biol Med (Maywood); 2009 Jan; 234(1):10-6. PubMed ID: 18997102
    [Abstract] [Full Text] [Related]

  • 2. Effect of atorvastatin and diet on non-alcoholic fatty liver disease activity score in hyperlipidemic chickens.
    Martín-Castillo A, Castells MT, Adánez G, Polo MT, Pérez BG, Ayala I.
    Biomed Pharmacother; 2010 Apr; 64(4):275-81. PubMed ID: 19932590
    [Abstract] [Full Text] [Related]

  • 3. Marked elevation of serum mitochondrion-derived markers in mild models of non-alcoholic steatohepatitis in rats.
    Murayama H, Ikemoto M, Nagata A.
    J Gastroenterol Hepatol; 2009 Feb; 24(2):270-7. PubMed ID: 18823438
    [Abstract] [Full Text] [Related]

  • 4. Preventive role of genistein in an experimental non-alcoholic steatohepatitis model.
    Yalniz M, Bahcecioglu IH, Kuzu N, Poyrazoglu OK, Bulmus O, Celebi S, Ustundag B, Ozercan IH, Sahin K.
    J Gastroenterol Hepatol; 2007 Nov; 22(11):2009-14. PubMed ID: 17914984
    [Abstract] [Full Text] [Related]

  • 5. Ezetimibe improves high fat and cholesterol diet-induced non-alcoholic fatty liver disease in mice.
    Zheng S, Hoos L, Cook J, Tetzloff G, Davis H, van Heek M, Hwa JJ.
    Eur J Pharmacol; 2008 Apr 14; 584(1):118-24. PubMed ID: 18329014
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Epigallocatechin gallate attenuates experimental non-alcoholic steatohepatitis induced by high fat diet.
    Kuzu N, Bahcecioglu IH, Dagli AF, Ozercan IH, Ustündag B, Sahin K.
    J Gastroenterol Hepatol; 2008 Aug 14; 23(8 Pt 2):e465-70. PubMed ID: 17683497
    [Abstract] [Full Text] [Related]

  • 8. Restriction of dietary calories, fat and iron improves non-alcoholic fatty liver disease.
    Yamamoto M, Iwasa M, Iwata K, Kaito M, Sugimoto R, Urawa N, Mifuji R, Konishi M, Kobayashi Y, Adachi Y.
    J Gastroenterol Hepatol; 2007 Apr 14; 22(4):498-503. PubMed ID: 17376040
    [Abstract] [Full Text] [Related]

  • 9. MCD-induced steatohepatitis is associated with hepatic adiponectin resistance and adipogenic transformation of hepatocytes.
    Larter CZ, Yeh MM, Williams J, Bell-Anderson KS, Farrell GC.
    J Hepatol; 2008 Sep 14; 49(3):407-16. PubMed ID: 18534710
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Apoptotic and anti-apoptotic seromarkers for assessment of disease severity of non-alcoholic steatohepatitis.
    El Bassat H, Ziada DH, Hasby EA, Nagy H, Abo Ryia MH.
    Arab J Gastroenterol; 2014 Mar 14; 15(1):6-11. PubMed ID: 24630506
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. The role of Kupffer cells in non-alcoholic steatohepatitis of rats chronically fed with high-fat diet.
    Fan J, Zhong L, Wang G, Wu X, Li M, Jing D, Zhang P.
    Zhonghua Gan Zang Bing Za Zhi; 2001 Feb 14; 9(1):16-8. PubMed ID: 11242127
    [Abstract] [Full Text] [Related]

  • 15. Psammomys obesus (sand rat), a new animal model of non-alcoholic fatty liver disease.
    Maislos M, Medvedovskv V, Sztarkier I, Yaari A, Sikuler E.
    Diabetes Res Clin Pract; 2006 Apr 14; 72(1):1-5. PubMed ID: 16242203
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Establishment and identification of non-alcoholic fatty liver disease in chronic hepatitis B virus infected mice].
    Zhang Z, Pan Q, Duan XY, Shi JP, Fan JG.
    Zhonghua Gan Zang Bing Za Zhi; 2011 Sep 14; 19(9):658-63. PubMed ID: 22152379
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Olmesartan severely weakened the development of NASH in an animal model of hypercholesterolemia.
    Sturzeneker MC, Ioshii SO, Villela Baroncini LA, Précoma DB.
    Atherosclerosis; 2011 May 14; 216(1):97-102. PubMed ID: 21338989
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.